Profile Trademark Details
Word Mark | Profile |
---|---|
Status | Dead Registered 710 — Cancelled - Section 8 |
Current Owner
Nova Pharmaceutical Corporation of Baltimore, MD
View all trademarks for Nova Pharmaceutical CorporationSerial Number | 73818393 |
---|---|
Registration Number | 1625349 |
Status Date | Monday, June 2, 1997 |
Filing Date | Monday, June 2, 1997 |
Registration Date | Tuesday, November 27, 1990 |
Attorney | E. Scott Johnson, Esq. |
Correspondent
E. SCOTT JOHNSON, ESQ.
OBER, KALER, GRIMES & SHRIVER
1600 MARYLAND NATIONAL BANK BUILDING
BALTIMORE, MD 21202
OBER, KALER, GRIMES & SHRIVER
1600 MARYLAND NATIONAL BANK BUILDING
BALTIMORE, MD 21202
Case File Statements
Goods & Services | Testing Services, Namely Screening Biologically Active Compounds for Selective Receptor Binding |
---|
Classifications
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100 |
Status | 2 — Sec. 8 – Entire Registration |
Status Date | Monday, June 2, 1997 |
First Use Anywhere | Thursday, December 1, 1988 |
First Use In Commerce | Monday, January 16, 1989 |
Primary Code | 042 |
Trademark Timeline
-
Dec 01 1988First use anywhere for the mark
-
Jan 16 1989First use in commerce for the mark
-
Aug 10 1989Trademark application filed with USPTO
-
Oct 13 1989Assigned To Examiner
-
Nov 29 1989Non-Final Action Mailed
-
Apr 20 1990Correspondence Received In Law Office
-
Jun 01 1990Approved For Pub - Principal Register
-
Aug 06 1990Notice of Publication
-
Aug 09 1990Notice of Publication
-
Sep 04 1990Published For Opposition
-
Nov 27 1990Registered-Principal Register
-
Nov 27 1990Trademark officially registered with the USPTO
-
Jun 02 1997Cancelled Sec. 8 (6-Yr)